These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1907202)

  • 21. Difference between human and guinea pig Hageman factors in activation by bacterial proteinases: cleavage site shift due to local amino acid substitutions may determine the activation efficiency of serine proteinase zymogens.
    Semba U; Shibuya Y; Tanase S; Nishino N; Makinose Y; Kambara T; Okabe H; Yamamoto T
    Biochim Biophys Acta; 1993 Jan; 1180(3):267-76. PubMed ID: 8422433
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factor XII-independent activation of the bradykinin-forming cascade: Implications for the pathogenesis of hereditary angioedema types I and II.
    Joseph K; Tholanikunnel BG; Bygum A; Ghebrehiwet B; Kaplan AP
    J Allergy Clin Immunol; 2013 Aug; 132(2):470-5. PubMed ID: 23672780
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A kallikrein-targeting RNA aptamer inhibits the intrinsic pathway of coagulation and reduces bradykinin release.
    Steen Burrell KA; Layzer J; Sullenger BA
    J Thromb Haemost; 2017 Sep; 15(9):1807-1817. PubMed ID: 28632925
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peptide synthesis catalysed by Pseudomonas aeruginosa elastase.
    Pauchon V; Besson C; Saulnier J; Wallach J
    Biotechnol Appl Biochem; 1993 Apr; 17(2):217-21. PubMed ID: 8484907
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of vascular permeability enhancement by human tryptase: dependence on activation of prekallikrein and direct release of bradykinin from kininogens.
    Imamura T; Dubin A; Moore W; Tanaka R; Travis J
    Lab Invest; 1996 May; 74(5):861-70. PubMed ID: 8642782
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanisms for the involvement of high molecular weight kininogen in surface-dependent reactions of Hageman factor.
    Griffin JH; Cochrane CG
    Proc Natl Acad Sci U S A; 1976 Aug; 73(8):2554-8. PubMed ID: 1066663
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Triggering of the vascular permeability reaction by activation of the Hageman factor-prekallikrein system by house dust mite proteinase.
    Maruo K; Akaike T; Matsumura Y; Kohmoto S; Inada Y; Ono T; Arao T; Maeda H
    Biochim Biophys Acta; 1991 May; 1074(1):62-8. PubMed ID: 2043681
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma prekallikrein: quantitative determination by direct activation with Hageman factor fragment (beta-XIIa).
    Alving BM; Tankersley DL; Mason BL
    J Lab Clin Med; 1983 Feb; 101(2):226-41. PubMed ID: 6549773
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prekallikrein activation in human, bovine, and rabbit plasmas: presence of an inhibitor in bovine plasma.
    Weerasinghe KM
    Inflammation; 1992 Jun; 16(3):205-13. PubMed ID: 1500097
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kinin-generating cascade in advanced cancer patients and in vitro study.
    Matsumura Y; Maruo K; Kimura M; Yamamoto T; Konno T; Maeda H
    Jpn J Cancer Res; 1991 Jun; 82(6):732-41. PubMed ID: 1906858
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathogenesis of serratial infection: activation of the Hageman factor-prekallikrein cascade by serratial protease.
    Matsumoto K; Yamamoto T; Kamata R; Maeda H
    J Biochem; 1984 Sep; 96(3):739-49. PubMed ID: 6438075
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The bradykinin-forming cascade: a historical perspective.
    Kaplan AP
    Chem Immunol Allergy; 2014; 100():205-13. PubMed ID: 24925400
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Activation of prekallikrein from human blood serum by different activators].
    Iarovaia GA; Dotsenko VL; Krizhevskaia IuV; Morozova NA; Orekhovich VN
    Biokhimiia; 1979 Jul; 44(7):1279-85. PubMed ID: 497275
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autoactivation of human plasma prekallikrein.
    Tans G; Rosing J; Berrettini M; Lämmle B; Griffin JH
    J Biol Chem; 1987 Aug; 262(23):11308-14. PubMed ID: 2440889
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potentiation of the function of Hageman factor fragments by high molecular weight kininogen.
    Liu CY; Scott CF; Bagdasarian A; Pierce JV; Kaplan AP; Colman RW
    J Clin Invest; 1977 Jul; 60(1):7-17. PubMed ID: 874091
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of Pseudomonas aeruginosa elastase and alkaline protease on serum complement and isolated components C1q and C3.
    Hong YQ; Ghebrehiwet B
    Clin Immunol Immunopathol; 1992 Feb; 62(2):133-8. PubMed ID: 1730152
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Hageman factor-dependent system in the vascular permeability reaction.
    Yamamoto T; Kozono K; Kambara T; Cochrane CG
    Biochim Biophys Acta; 1988 Aug; 966(2):196-206. PubMed ID: 3401504
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The binding and cleavage characteristics of human Hageman factor during contact activation. A comparison of normal plasma with plasmas deficient in factor XI, prekallikrein, or high molecular weight kininogen.
    Revak SD; Cochrane CG; Griffin JH
    J Clin Invest; 1977 Jun; 59(6):1167-75. PubMed ID: 864009
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of cleavage sites involved in proteolytic processing of Pseudomonas aeruginosa preproelastase.
    Kessler E; Safrin M; Peretz M; Burstein Y
    FEBS Lett; 1992 Mar; 299(3):291-3. PubMed ID: 1544509
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of prekallikrein and high-molecular-weight kininogen in the contact activation of Hageman factor (factor XII) by sulfatides and other agents.
    España F; Ratnoff OD
    J Lab Clin Med; 1983 Oct; 102(4):487-99. PubMed ID: 6604770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.